- Home
- GEVO vs OABI Comparison
GEVO vs OABI Comparison
Compare GEVO & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEVO
- OABI
- Stock Information
- Founded
- GEVO 2005
- OABI 2012
- Country
- GEVO United States
- OABI United States
- Employees
- GEVO N/A
- OABI N/A
- Industry
- GEVO Major Chemicals
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- GEVO Industrials
- OABI Health Care
- Exchange
- GEVO Nasdaq
- OABI Nasdaq
- Market Cap
- GEVO 330.4M
- OABI 307.4M
- IPO Year
- GEVO 2011
- OABI N/A
- Fundamental
- Price
- GEVO $1.14
- OABI $2.28
- Analyst Decision
- GEVO Buy
- OABI Strong Buy
- Analyst Count
- GEVO 2
- OABI 3
- Target Price
- GEVO $8.63
- OABI $7.00
- AVG Volume (30 Days)
- GEVO 3.2M
- OABI 780.2K
- Earning Date
- GEVO 03-27-2025
- OABI 03-18-2025
- Dividend Yield
- GEVO N/A
- OABI N/A
- EPS Growth
- GEVO N/A
- OABI N/A
- EPS
- GEVO N/A
- OABI N/A
- Revenue
- GEVO $16,915,000.00
- OABI $26,391,000.00
- Revenue This Year
- GEVO N/A
- OABI $77.72
- Revenue Next Year
- GEVO $917.63
- OABI $30.95
- P/E Ratio
- GEVO N/A
- OABI N/A
- Revenue Growth
- GEVO N/A
- OABI N/A
- 52 Week Low
- GEVO $0.48
- OABI $2.23
- 52 Week High
- GEVO $3.39
- OABI $5.54
- Technical
- Relative Strength Index (RSI)
- GEVO 34.22
- OABI 27.98
- Support Level
- GEVO $1.09
- OABI $2.38
- Resistance Level
- GEVO $1.34
- OABI $2.57
- Average True Range (ATR)
- GEVO 0.09
- OABI 0.18
- MACD
- GEVO 0.00
- OABI -0.04
- Stochastic Oscillator
- GEVO 12.50
- OABI 4.42
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. Its operating segments are the Gevo segment, Renewable Natural Gas Segment, and the Agri-Energy segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.